Elevance Health, Inc. (NYSE:ELV) is a US-based health benefits company, which the strategy initiated a position during the quarter. On July 31, 2026, Elevance Health, Inc. (NYSE:ELV) closed at $375.84 per share, reflecting a market capitalization of $81.54 billion. Elevance Health, Inc. (NYSE:ELV) posted a one-month return of -10.03%, while its shares gained 32.82% over the past 52 weeks. UBS Reaffirms Buy on Elevance Health (ELV) Amid Stronger Industry TrendsElevance Health, Inc. (NYSE:ELV) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.